You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股盤面 | 新能源車和郵輪概念拉漲
uSMART友信智投 09-04 21:37

週五美股開盤,美股三大指數漲跌不一,標普500指數漲0.07%;納斯達克指數跌0.48%;道瓊斯指數漲0.51%。

個股消息

天境生物(IMAB.US)漲14.97%,該公司和艾伯維(ABBV.US)今天共同宣佈,雙方就Lemzoparlimab(TJC4)的開發和商業化建立廣泛的全球戰略合作關係。TJC4是由天境生物自主研發的、用於治療多種癌症的創新型CD47單克隆抗體。此外,未來雙方或將擴大合作,共同開發其他聯合治療方案。

安派科(ANPC.US)漲13.34%,該公司與中國一家主流醫院合作成功完成了一項多年期肺癌預後和復發研究的積極成果。據悉該臨牀研究項目始於2014年,該項目使用AnPac Bio的癌症分化分析(CDA)技術在臨牀研究中對大約1000名確診的肺癌患者進行了測試。

Curevac(CVAC.US)漲4.02%,該公司臨時從德國獲得高達2.52億歐元的資助。馬斯克此前拜訪該公司,並討論CureVac與特斯拉(TSLA.US)德國子公司Grohmann之間的合作。有媒體表示,馬斯克此行或爲商談特斯拉建設RNA微型工廠。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account